TECH

58.63

0.17% -0.10

Handel nachbörslich: 58.63

Bio Techne Corp (TECH)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$58.73

Offen:

$57.98

24-Stunden-Volumen:

1.47M

Relative Volume:

1.03

Marktkapitalisierung:

$9.65B

Einnahmen:

$1.17B

Nettoeinkommen (Verlust:

$150.71M

KGV:

62.37

EPS:

0.94

Netto-Cashflow:

$245.03M

1W Leistung:

-4.00%

1M Leistung:

-5.05%

6M Leistung:

-26.65%

1J Leistung:

-16.71%

1-Tages-Spanne:

$56.70

$59.20

1-Wochen-Bereich:

$56.70

$61.86

52-Wochen-Spanne:

$56.60

$85.57

Bio Techne Corp Stock (TECH) Company Profile

Firmenname

Bio Techne Corp

Sektor

Healthcare (1164)

Branche

Biotechnology (681)

Telefon

(612) 379-8854

Adresse

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Mitarbeiter

Twitter

@biotechne

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

TECH's Discussions on Twitter

Vergleichen Sie TECH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TECH Bio Techne Corp	58.63	9.65B	1.17B	150.71M	245.03M	0.94
VRTX Vertex Pharmaceuticals Inc	484.82	131.41B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	634.23	72.26B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	591.87	36.10B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	270.02	35.03B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	272.17	28.24B	3.81B	-644.79M	-669.77M	-6.24

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-18	Eingeleitet	Evercore ISI	Outperform
2025-02-19	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-02-08	Eingeleitet	Scotiabank	Sector Outperform
2024-02-02	Herabstufung	Stifel	Buy → Hold
2023-12-07	Eingeleitet	UBS	Buy
2023-08-28	Eingeleitet	William Blair	Outperform
2023-01-10	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Sector Perform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-04-25	Herabstufung	Wells Fargo	Equal Weight → Underweight
2021-09-15	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-08	Hochstufung	Stephens	Equal-Weight → Overweight
2021-02-23	Hochstufung	Stifel	Hold → Buy
2021-01-25	Bestätigt	The Benchmark Company	Buy
2020-11-10	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2020-09-30	Eingeleitet	Atlantic Equities	Overweight
2020-07-15	Herabstufung	Stephens	Overweight → Equal-Weight
2020-05-27	Herabstufung	Stifel	Buy → Hold
2020-05-14	Eingeleitet	The Benchmark Company	Buy
2020-01-08	Fortgesetzt	Stephens	Overweight
2020-01-08	Eingeleitet	Wells Fargo	Equal Weight
2020-01-07	Eingeleitet	Citigroup	Neutral
2019-11-15	Eingeleitet	Stifel	Buy
2019-07-02	Hochstufung	Janney	Neutral → Buy
2019-01-14	Hochstufung	Stephens	Equal-Weight → Overweight
2018-10-31	Herabstufung	Craig Hallum	Buy → Hold
2018-10-17	Eingeleitet	Goldman	Neutral
2018-06-15	Eingeleitet	Argus	Buy
2017-07-13	Eingeleitet	Wells Fargo	Market Perform
2017-02-09	Eingeleitet	Citigroup	Buy
2017-01-18	Eingeleitet	Deutsche Bank	Buy
2016-11-10	Fortgesetzt	Leerink Partners	Outperform
2015-01-21	Bestätigt	Robert W. Baird	Outperform
2013-09-20	Hochstufung	Robert W. Baird	Neutral → Outperform

Alle ansehen

Bio Techne Corp Aktie (TECH) Neueste Nachrichten

10:00 AM

Bio-Techne Opens New Customer Experience Centre in Germany - Yahoo Finance

10:00 AM

05:12 AM

3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Yahoo Finance

05:12 AM

Mar 28, 2025

Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch - Yahoo Finance

Mar 28, 2025

Mar 26, 2025

Bio-Techne to Open New Customer Facility in Germany - Marketscreener.com

Mar 26, 2025

Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany - Yahoo Finance

Mar 26, 2025

Mar 24, 2025

Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting - Quantisnow

Mar 24, 2025

Game-Changing Cancer Detection Technology: RNAscope Shows Superior Results in Multiple Tumors - Stock Titan

Mar 24, 2025

Mar 19, 2025

Bio-Techne Earnings Preview: What to Expect - MSN

Mar 19, 2025

Evercore ISI Group Initiates Coverage of Bio-Techne (TECH) with Outperform Recommendation - MSN

Mar 19, 2025

Mar 18, 2025

Evercore ISI sets Bio-Techne stock Outperform with $75 target By Investing.com - Investing.com South Africa

Mar 18, 2025

6 Analysts Assess Bio-Techne: What You Need To Know - Benzinga

Mar 18, 2025

Evercore ISI sets Bio-Techne stock Outperform with $75 target - Investing.com

Mar 18, 2025

Mar 17, 2025

Bio-Techne: A Premium Growth Asset with Strong Market Position and Promising Future - TipRanks

Mar 17, 2025

Bio-Techne (NASDAQ:TECH) shareholders have earned a 8.3% CAGR over the last five years - Yahoo Finance

Mar 17, 2025

Mar 13, 2025

Bio-Techne Co. (NASDAQ:TECH) Receives $82.14 Consensus Price Target from Analysts - Defense World

Mar 13, 2025

Mar 12, 2025

Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.

Mar 12, 2025

Bio Techne at Barclays Conference: Strategic Growth Amid Market Challenges - Investing.com

Mar 12, 2025

TECH Stock Might Rise Following the Leo Shipping Announcement - Nasdaq

Mar 12, 2025

Mar 11, 2025

Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

Mar 11, 2025

Bio-Techne at Leerink’s Global Healthcare Conference: Strategic Growth Amid Challenges - Investing.com India

Mar 11, 2025

Techne Corp stock hits 52-week low at $58.94 amid market shifts - Investing.com India

Mar 11, 2025

Techne Corp stock hits 52-week low at $58.94 amid market shifts By Investing.com - Investing.com South Africa

Mar 11, 2025

GC Wealth Management RIA LLC Takes $805,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Mar 11, 2025

Mar 10, 2025